Rita Balice-Gordon is the founder of Muna Therapeutics. Muna Therapeutics has raised $73M in total funding. Latest round: Series A.
Rita J. Balice-Gordon, Ph.D., is the Chief Executive Officer of Muna Therapeutics, a biotech company focused on disease-modifying therapies for neurodegenerative diseases. She previously worked as a faculty member at the University of Pennsylvania, researching neural development and plasticity. In July 2021, she led Muna Therapeutics to raise $73 million in Series A funding.
Full founder directory · Investor directory · Company funding database · Fundraising library